Antibody ReportsMolecular BiologyPeer-reviewed journal article
AI334 and AQ806 antibodies recognize the spike S protein from SARS-CoV-2 by ELISA
Philippe HammeliD, Anna MarchettiiD, Wanessa Cristina de Lima, Kelvin LauiD, Florence PojeriD, David L. HackeriD, Pierre CossoniD
Abstract
We tested 10 recombinant antibodies directed against the spike S protein from SARS-CoV-1. Among them, antibodies AI334 and AQ806 detect by ELISA the spike S protein from SARS-CoV-2.
- Citations
- 6
- FWCI
- 0.20
- Field percentile
- top 32%
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Validation and performance of a quantitative IgG assay for the screening of SARS-CoV-2 antibodies
A. M. Espino, P. Pantoja, C. A. Sariol·bioRxiv·Jun 11, 2020
- Evaluation of the EUROIMMUN Anti-SARS-CoV-2 ELISA Assay for detection of IgA and IgG antibodies
S. Matushek, K. G. Beavis, … V. Tesic·Journal of Clinical VirologyPeer-reviewed·Aug 1, 2020
- Monoclonal antibodies for the S2 subunit of spike of SARS-CoV cross-react with the newly-emerged SARS-CoV-2
Z. Zheng, V. M. Monteil, … Y.-J. Tan·EurosurveillancePeer-reviewed·Jul 16, 2020
- Comparative analyses of SARS-CoV-2 binding (IgG, IgM, IgA) and neutralizing antibodies from human serum samples
L. Mazzini, D. Martinuzzi, … E. Montomoli·bioRxiv·Aug 10, 2020
- A simple protein-based surrogate neutralization assay for SARS-CoV-2
K. T. Abe, Z. Li, … A.-C. Gingras·bioRxiv·Jul 10, 2020
- A cell-based, spike protein binding assay highlights differences in antibody neutralising capacity for SARS-CoV-2 variants
N. Harrison, L. Richardson, … O. S. Qureshi·bioRxiv·Jun 24, 2022